Evidence map›Paper›PMID 35338581›Full record

ArticleTransboundary and emerging diseases2022

Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021.

Maya Holding, Ashley David Otter, Stuart Dowall, Katsuhisa Takumi, Bethany Hicks, Tom Coleman, Georgia Hemingway, Matthew Royds, Stephen Findlay-Wilson, Mollie Curran-French and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. High Exposure to Livestock Pathogens in Southern Pudu (Animals : an open access journal from MDPI · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SARS-CoV-2 Neutralizing Antibodies in Free-Ranging Fallow Deer (Transboundary and emerging diseases · 2023
    Article
  12. Article
  13. Wild Red Deer (Viruses · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Maya HoldingVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.ORCID https://orcid.org/0000-0001-6666-5855
Ashley David OtterSARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
Stuart DowallVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Katsuhisa TakumiCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Bethany HicksSARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
Tom ColemanSARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
Georgia HemingwaySARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
Matthew RoydsSARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
Stephen Findlay-WilsonVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Mollie Curran-FrenchVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Richard VipondVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Hein SprongCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Roger HewsonVirology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Public Health England · GBNational Institute for Public Health and the Environment · NLUniversity of Liverpool · GBUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small.

Indexed as

COVID-19DeerAnimalsAnimals, WildAntibodies, ViralCOVID-19 TestingHumansSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 serological testingdeerSARS-CoV-2sentinel surveillanceUnited Kingdomviral zoonoses

Identifiers

PMID35338581
PMCPMC9115462
OpenAlexW4220703125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.